BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 3779372)

  • 21. Disturbances in higher function in Parkinson's disease.
    Tamaru F
    Eur Neurol; 1997; 38 Suppl 2():33-6. PubMed ID: 9387801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
    Robbins TW; James M; Owen AM; Lange KW; Lees AJ; Leigh PN; Marsden CD; Quinn NP; Summers BA
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):79-88. PubMed ID: 8301310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes.
    Monza D; Soliveri P; Radice D; Fetoni V; Testa D; Caffarra P; Caraceni T; Girotti F
    Arch Neurol; 1998 Mar; 55(3):372-8. PubMed ID: 9520011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
    Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.
    Gotham AM; Brown RG; Marsden CD
    Brain; 1988 Apr; 111 ( Pt 2)():299-321. PubMed ID: 3378138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.
    Marié RM; Barré L; Dupuy B; Viader F; Defer G; Baron JC
    Neurosci Lett; 1999 Jan; 260(2):77-80. PubMed ID: 10025703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociating executive functions of the prefrontal cortex.
    Robbins TW
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1463-70; discussion 1470-1. PubMed ID: 8941958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in theta activities in the left posterior temporal region, left occipital region and right frontal region related to mild cognitive impairment in Parkinson's disease patients.
    He X; Zhang Y; Chen J; Xie C; Gan R; Wang L; Wang L
    Int J Neurosci; 2017 Jan; 127(1):66-72. PubMed ID: 26785609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.
    Müller U; Wächter T; Barthel H; Reuter M; von Cramon DY
    J Neural Transm (Vienna); 2000; 107(3):303-19. PubMed ID: 10821439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.
    Owen AM
    Neuroscientist; 2004 Dec; 10(6):525-37. PubMed ID: 15534038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease.
    Habak C; Noreau A; Nagano-Saito A; Mejía-Constaín B; Degroot C; Strafella AP; Chouinard S; Lafontaine AL; Rouleau GA; Monchi O
    Brain; 2014 Nov; 137(Pt 11):3025-35. PubMed ID: 25212851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Procedural learning and Parkinson disease: implication of striato-frontal loops].
    Sarazin M; Deweer B; Pillon B; Merkl A; Dubois B
    Rev Neurol (Paris); 2001 Dec; 157(12):1513-8. PubMed ID: 11924447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive planning in humans: neuropsychological, neuroanatomical and neuropharmacological perspectives.
    Owen AM
    Prog Neurobiol; 1997 Nov; 53(4):431-50. PubMed ID: 9421831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slowing of reaction time in Parkinson's disease: the involvement of the frontal lobes.
    Berry EL; Nicolson RI; Foster JK; Behrmann M; Sagar HJ
    Neuropsychologia; 1999 Jun; 37(7):787-95. PubMed ID: 10408646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.
    Owen AM; Roberts AC; Hodges JR; Summers BA; Polkey CE; Robbins TW
    Brain; 1993 Oct; 116 ( Pt 5)():1159-75. PubMed ID: 8221053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome".
    Taylor AE; Saint-Cyr JA; Lang AE
    Brain Cogn; 1990 Jul; 13(2):211-32. PubMed ID: 2390235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedural learning and striatofrontal dysfunction in Parkinson's disease.
    Sarazin M; Deweer B; Merkl A; Von Poser N; Pillon B; Dubois B
    Mov Disord; 2002 Mar; 17(2):265-73. PubMed ID: 11921111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.
    Lewis SJ; Cools R; Robbins TW; Dove A; Barker RA; Owen AM
    Neuropsychologia; 2003; 41(6):645-54. PubMed ID: 12591022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.